Medical Breakthroughs from Penn Medicine

Sep 29 2022 113 ep. 7.2k

Medical Breakthroughs from Penn Medicine Podcast artwork

Medical Breakthroughs features the newest medical advancements in the areas of oncology, cardiology, neurosciences, orthopedics, and genetics featuring America’s leading physicians and medical researchers from Penn Medicine.

Copy RSS

Subscribe on Podcast Addict

Considering CAR T-cell Therapy in Follicular Lymphoma

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Elise Chong, MD Patients with follicular lymphoma who relapse or don’t respond to treatment don’t have many therapeutic options, but a recently FDA-approved CAR T-cell therapy may help change that. Dr. Charles Turck is joined by Dr. Elise Chong from Penn Medicine’s Abramson Cancer Center to explore this new treatment op

Healing at Home: Advancements in Screening for Postpartum Depression

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Kirstin Leitner, MD Current screening tools for postpartum depression may have limitations, but a new texting service as part of the Healing at Home program may help clinicians detect postpartum depression earlier. Dr. Charles Turck is joined by Dr. Kirstin Leitner to take a look at this program and its impacts.

A Peek Inside the Pavilion: Exploring Penn Medicine’s Newest Facility

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Kathryn Gallagher, MS, RN, BSN Guest: Kate Newcomb-DeSanto, MSN, RN, MSW What does Penn Medicine’s newly-opened patient room facility have to offer? Dr. Charles Turck is joined by Penn Medicine Clinical Advisors Kathy Gallagher and Kate Newcomb-DeSanto to discuss the new pavilion and how it's revolutionizing patient care

Exploring the Benefits & Safety of COVID-19 Vaccine Technology

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Drew Weissman, MD, PhD Dr. Drew Weissman, Professor of Medicine at Penn Medicine joins Dr. Turck to discuss his new COVID-19 vaccine technology and how RNA and mRNA are being used to provoke an immune response in order to combat the COVID-19 pandemic.

Updates in Uterine Factor Infertility: The Promise of Transplants

Host: Jennifer Caudle, DO Guest: Kathleen E. O'Neill, MD, MTR Guest: Nawar Abdul Latif, MD, MPH, MSCE Patients with uterine factor infertility, or UFI, only had two options if they wanted to achieve parenthood: using a gestational carrier or adoption. Until now. Joining Dr. Jennifer Caudle to talk about the opportunities of uterine transplants and key information a

Expanding Options for the Management of Multiple Sclerosis

Host: Jennifer Caudle, DO Guest: Amit Bar-Or, MD, FRCP, FAAN, FANA Joining Dr. Jennifer Caudle to discuss the latest research furthering our understanding and treatment of multiple sclerosis is Dr. Amit Bar-Or, Chief of the Multiple Sclerosis Division and Director for the Center of Neuroinflammation and Neurotherapeutics at Penn Medicine. Could these recent findings finall

Gaining a Deeper Understanding of Inherited Cardiomyopathy

Host: Jennifer Caudle, DO Guest: Anjali Owens, MD Without any targeted therapies available for inherited cardiomyopathy, how can we treat our patients coping with its debilitating symptoms? Here to share her diagnostic and management strategies along with key data from a recent study is Dr. Anjali Owens, Medical Director at the Center for Inherited Heart Disease at Penn Me

Endeavors of the Heart: Leveraging Innovative Technologies for Transcatheter Therapies

Host: Matt Birnholz, MD Guest: Howard C. Herrmann, MD Twelve years after performing the first transcatheter aortic valve replacement, Penn Medicine continues to gain momentum in the transformation of cardiovascular transcatheter therapies. Dr. Howard Herrmann recounts the evolution in alternative technologies to improve patient safety and outcomes and the role these advanc

Reinventing Autologous Breast Reconstruction to Reduce Pain & Postsurgical Opioid Use

Host: Jennifer Caudle, DO Guest: Suhail K. Kanchwala, MD Improving his patients’ post-surgical experience was Dr. Suhail Kanchwala's goal when he sought to develop a new method for autologous breast reconstruction. The result of his search has brought a new technique to the field, along with an array of benefits for patients, including reduction of post-surgical pain and

FDA-Approved Gene Therapy Reverses Blindness in Children & Adults

Host: Jennifer Caudle, DO Guest: Jean Bennett, MD, PhD Guest: Albert Maguire, MD Power couple Drs. Jean Bennett and Albert Maguire discuss how their new therapy for the RPE65 gene, which causes retinal blindness, was recently approved by the FDA to become the first gene therapy treatment for a genetic disease in the United States and the first worldwide treatment for in